USPTO serial 87120948
APCER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 27, 2018
- Examiner
- KHAN, ASMAT A
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with APCER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Leicestershire, GB
Leicestershire, GB
Leicestershire, GB
GUILDFORD, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aisling E. Altidore
Aisling E. Altidore PANDISCIO & PANDISCIO83 Walnut StreetSuite 150Wellesley, MA 02481Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies | ACTIVE | Sep 30, 2008 |
| 042 | Pharmacovigilance healthcare support services, namely, pharmaceutical product evaluation; Clinical safety services, namely, monitoring of pharmaceuticals and vaccines which are under clinical development programs of pharmaceutical, biotechnology, consumer health, vaccine and device companies for quality control purposes | ACTIVE | Sep 30, 2008 |
| 044 | Healthcare support services, namely, providing medical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals | ACTIVE | Sep 30, 2008 |
| 045 | Regulatory compliance consulting in the fields of new pharmaceutical and vaccine products; Providing information concerning consumer product safety in the fields of pharmaceuticals and vaccines; Providing pharmaceutical product safety information to pharmaceutical, biotechnology, consumer health, vaccine and device companies | ACTIVE | Sep 30, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by APCER Pharma Europe Ltd.
- Other trademarks owned by APCER Pharma Europe Ltd.
- Other trademarks owned by APCER Pharma Europe Ltd.
- Other trademarks owned by APCER LIFE SCIENCES LTD.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named APCER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 28, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 28, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 27, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 27, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 27, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 27, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 9, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 20, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 5, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 5, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 7, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 7, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 7, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 30, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |